Home Print this page Email this page Users Online: 76
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 26  |  Issue : 1  |  Page : 103-105

Therapeutic management of the enzymatic debriding agent Nexobrid® in the burn patient

Department of Plastic Surgery and Burns, University and Polytechnic Hospital La Fe, Valencia, Spain

Correspondence Address:
Dr. Enrique Salmeron-Gonzalez
25 Francia Avenue, Stairs 2, Appt #25, 9th Floor, Valencia, Comunidad Valenciana 46013
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijb.ijb_32_17

Rights and Permissions

Enzymatic debridement with Nexobrid® is a recently appeared resource, which allows a selective elimination of burned tissues with one single application, becoming a new resource in the therapeutic arsenal of the burn surgeon. In this article, we expose our experience with this product, and through a representative case, we explain the management of these patients performed in our burns unit, in consonance with national and international consensus.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal